Goals of Care and Patient-Centric Outcomes for Checkpoint Inhibitor Immunotherapy in Patients With Limited Performance Status
JCO Oncol Pract
.
2022 Jan;18(1):4-6.
doi: 10.1200/OP.21.00552.
Epub 2021 Sep 7.
Authors
Ryan C Augustin
1
,
Jason J Luke
1
Affiliation
1
UPMC Hillman Cancer Center and University of Pittsburgh, Pittsburgh, PA.
PMID:
34491786
PMCID:
PMC8758124
DOI:
10.1200/OP.21.00552
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
Humans
Immunotherapy*
Patient Care Planning
Patient-Centered Care*
Grants and funding
P30 CA047904/CA/NCI NIH HHS/United States
UM1 CA186690/CA/NCI NIH HHS/United States